Document Detail

Multifaceted kinetics of immuno-evasion from tumor dormancy.
MedLine Citation:
PMID:  23143978     Owner:  NLM     Status:  In-Data-Review    
Tumor progression is subject to modulation by the immune system. The immune system can eliminate tumors or keep them at a dormant equilibrium size, while some tumors escape immunomodulation and advance to malignancy. Herein, we discuss some aspects of immune evasion of dormant tumors from a theoretical biophysics point of view that can be modeled mathematically. We go on to analyze the mathematical system on multiple timescales. First, we consider a long timescale where tumor evasion is likely due to adaptive (and somewhat deterministic) immuno-editing. Then, we consider the temporal mesoscale and hypothesize that extrinsic noise could be a major factor in induction of immuno-evasion. Implications of immuno-evasive mechanisms for the outcome of immunotherapies are also discussed. In addition, we discuss the ideas that population level tumor dormancy may not be a quiescence phenomenon and that dormant tumors can, at least if modulated by the immune system, live a very active and noisy life!
Alberto d'Onofrio
Related Documents :
24801008 - Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow coppe...
24132648 - Early prediction of treatment response to sorafenib with elastosonography in a mice xen...
12651608 - Role of cd31/platelet endothelial cell adhesion molecule-1 expression in in vitro and i...
12547698 - Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant ...
7814198 - Glomus tumor of the female external genitalia: a report of two cases.
688178 - Induction of thyroid follicular adenomas and carcinomas by n-nitrosobis(2-oxopropyl)amine.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  734     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  2013  
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  111-43     Citation Subset:  IM    
Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, Milano, 20141, Italy,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.
Next Document:  Tumor dormancy and cancer stem cells: two sides of the same coin?